DESIGNING ANTI-PDL1 ANTIBODY CONJUGATED POLYMERIC COACERVATES AS A NOVEL “NANO-IMMUNOTHERAPY” AGAINST HEPATOCELLULAR CARCINOMA
Ph.D
Saved in:
Main Author: | CHERYLETTE ANNE ALEXANDER |
---|---|
Other Authors: | DEAN'S OFFICE (NUS GRADUATE SCHOOL) |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/243117 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
by: Zhao Y., et al.
Published: (2019) -
First-line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
by: Fong K.Y., et al.
Published: (2022) -
Global epidemiology and genetics of hepatocellular carcinoma
by: Toh, Ming Ren, et al.
Published: (2023) -
Circulating markers for prognosis of hepatocellular carcinoma
by: Wong, K.-F., et al.
Published: (2014) -
Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression
by: Chong, Yong Chun, et al.
Published: (2020)